Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-08

FDA Approved: TELMISARTAN — Original Application (Chartwell RX, LLC.)

View source ↗

Summary

The FDA approved Chartwell RX, LLC.'s original application for a generic telmisartan, expanding access to treatment for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

ORIG AP for TELMISARTAN (TELMISARTAN)